Chapter 7: Pharmacogenomics.

Chapter 7: Pharmacogenomics.
复制标题

DOI:
10.1371/journal.pcbi.1002817
复制
发表时间:
2012
影响因子:
4.3
通讯作者:
Altman RB
Altman RB
中科院分区:
生物学2区
文献类型:
--
作者:
Karczewski KJ;Daneshjou R;Altman RB

文献摘要

参考文献

被引文献

相似文献

药物反应表型有很大的差异,“一刀切”的药物输送模式是有缺陷的。药物基因组学是研究人类遗传信息如何影响药物反应的科学,其目的是提高疗效和减少副作用。在这篇文章中,我们提供了药物遗传学的概述,包括药代动力学(PK),药效学(PD),基因和途径的相互作用,脱靶效应。我们描述了发现药物反应中遗传因素的方法,包括全基因组关联研究(GWAS),表达分析和其他方法,如化学信息学和自然语言处理(NLP)。我们涵盖了药物基因组学在制药行业和临床环境中的实际应用。在药物发现中,药物基因组学可用于辅助先导物识别、预测不良事件并协助药物再利用工作。此外,药物基因组学的发现显示出作为医生决策支持的重要因素的希望。最后,我们考虑药物基因组学的临床实施仍然存在的伦理,监管和报销的挑战。
There is great variation in drug-response phenotypes, and a “one size fits all” paradigm for drug delivery is flawed. Pharmacogenomics is the study of how human genetic information impacts drug response, and it aims to improve efficacy and reduced side effects. In this article, we provide an overview of pharmacogenetics, including pharmacokinetics (PK), pharmacodynamics (PD), gene and pathway interactions, and off-target effects. We describe methods for discovering genetic factors in drug response, including genome-wide association studies (GWAS), expression analysis, and other methods such as chemoinformatics and natural language processing (NLP). We cover the practical applications of pharmacogenomics both in the pharmaceutical industry and in a clinical setting. In drug discovery, pharmacogenomics can be used to aid lead identification, anticipate adverse events, and assist in drug repurposing efforts. Moreover, pharmacogenomic discoveries show promise as important elements of physician decision support. Finally, we consider the ethical, regulatory, and reimbursement challenges that remain for the clinical implementation of pharmacogenomics.
DOI: 10.1136/ard.2005.046797
发表时间: 2006-09-01
影响因子: 27.4
作者:
Hughes, L. B.;Beasley, T. M.;Bridges, S. L., Jr.
通讯作者: Bridges, S. L., Jr.
DOI: 10.1016/s0009-9236(03)00068-7
发表时间: 2003-07-01
影响因子: 6.7
作者:
Johnson, JA;Zineh, I;Pauly, DF
通讯作者: Pauly, DF
DOI: 10.1016/s0140-6736(10)60452-7
发表时间: 2010-05-01
期刊: LANCET
影响因子: 168.9
作者:
Ashley, Euan A.;Butte, Atul J.;Wheeler, Matthew T.;Chen, Rong;Klein, Teri E.;Dewey, Frederick E.;Dudley, Joel T.;Ormond, Kelly E.;Pavlovic, Aleksandra;Morgan, Alexander A.;Pushkarev, Dmitry;Neff, Norma F.;Hudgins, Louanne;Gong, Li;Hodges, Laura M.;Berlin, Dorit S.;Thorn, Caroline F.;Sangkuhl, Katrin;Hebert, Joan M.;Woon, Mark;Sagreiya, Hersh;Whaley, Ryan;Knowles, Joshua W.;Chou, Michael F.;Thakuria, Joseph V.;Rosenbaum, Abraham M.;Zaranek, Alexander Wait;Church, George M.;Greely, Henry T.;Quake, Stephen R.;Altman, Russ B.
通讯作者: Altman, Russ B.
DOI: 10.1016/s0140-6736(04)17273-5
发表时间: 2004-10-23
期刊: LANCET
影响因子: 168.9
作者:
Israel, E;Chinchilli, VM;Drazen, JM
通讯作者: Drazen, JM
DOI: 10.1097/fpc.0b013e3282f60aad
发表时间: 2008-04-01
影响因子: 2.6
作者:
Donnelly, Louise A.;Palmer, Colin N. A.;Donnan, Peter T.
通讯作者: Donnan, Peter T.